Tekla Capital Management LLC Ac Immune Sa Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$5.32 - $8.96 $914,045 - $1.54 Million
-171,813 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$10.37 - $12.85 $1.36 Million - $1.68 Million
130,894 Added 319.89%
171,813 $2.2 Million
Q3 2017

Nov 13, 2017
BUY
$7.06 - $11.2 $288,888 - $458,292
40,919
40,919 $462,000

Others Institutions Holding ACIU

# of Institutions
43
Shares Held
26.8M
Call Options Held
94.9K
Put Options Held
22.5K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $276M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email